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Abstract Some researchers claim that health care
expenditures for older people are growing faster than for
the rest of the population. This process is referred to as
steepening. The aim of this paper is to test steepening,
applying new data and revised methods. Furthermore, we
explain the connection between the terms red herring
hypothesis, i.e., that time to death and not age per se drives
the health care expenditures, and steepening. We also
present the mechanisms that may induce steepening, as
presented in the literature. When testing steepening, we
apply data from all inpatient stays in somatic hospitals in
Norway in the period 1998–2009, i.e., the data has no self-
selection and covers the entire population of Norway (5
million). Our analysis does not reject steepening, with the
exception of the 0-year-olds. The results also hold when
controlling for mortality-related expenditures. Further-
more, we observe an increase in expenditures for the
0-year-olds. Finally, we find increasing mortality-related
expenditures over time. We find the link between steep-
ening and the red herring hypothesis to be vague, and we
find steepening and the red herring hypothesis to be
independent.
Keywords Red herring hypothesis  Hospital
expenditure  Trends in health care expenditures 
Steepening  Ageing
JEL Classifications A19  I15  I19
Introduction
The proportion of the elderly population in the countries of
the Organization for Economic Co-operation and Develop-
ment (OECD) will increase substantially in the coming
years. Knowledge regarding the distribution of per capita
health care costs between different age groups is essential in
order to forecast future health care expenditures. In this
study, we discuss the long-term development of health care
expenditures. Even though the long-term developments for
the entire population are discussed in detail in several papers
[1, 2], the specific increase for different age groups is poorly
covered. This is vital in order to understand the long-term
developments in health care expenditures. In this paper, we
will investigate the specific growth for different age groups.
When discussing trends in health care expenditures,
two concepts are often brought up in the literature: red
herring hypothesis and steepening. The red herring
hypothesis states that health care expenditures are driven
by time to death, not age per se [3]. Steepening states
that the growth in per capita health care expenditures for
older people is higher than for the rest of the population
[4]. In this paper, we will focus on the latter, but clarify
the relation between the terms. The aim of the clarifi-
cation is threefold. First, in the literature [4, 5], the
connection between steepening and the red herring is
vaguely described, so a clarification will therefore con-
tribute to the steepening literature. Second, a discussion
of the link between the terms will contribute to further
understanding of the concept of steepening. Third, sev-
eral methodological issues discussed in the red herring
debate also apply in the steepening debate, and hence
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bringing in the red herring literature will improve the
steepening debate.
The aim of this paper is threefold. First, we measure
changes in health care expenditures over time, in order to
test if steepening may be rejected. Second, we present
mechanisms that may induce steepening, as presented in
the literature. Third, we attempt explain the connection
between red herring and steepening.
When testing steepening, we apply a complete data set for
inpatient hospital expenditures in Norway from 1998 to
2009. We use diagnostic related groups (DRG) weights to
measure the hospital expenditures. Norway has a National
Health Service similar to the one we find in other Scandi-
navian countries and the United Kingdom (UK). The hos-
pitals are public and financed through general taxation [6].
The contribution of this paper is that we elaborate on the
link between red herring and steepening more than has
previously been done in the literature [4, 5]. We also
summarize the literature on mechanisms that may induce
steepening. Furthermore, the estimation techniques previ-
ously presented in the literature are improved and the
previous methods are replicated. The data set applied to
test steepening is of high quality, with no self-selection
over a long period of time.
The paper proceeds as follows: first, we present the
terms steepening and red herring with the present litera-
ture, and discuss in detail what may induce steepening.
Secondly, we explain the link between the two concepts.
Thirdly, we test steepening. In the third part, we first
present the data, then the methods and the results. Fourth,
we present the conclusion and discussion.
Background
‘‘If steepening [occurs]…, the future increase of health care
costs will even be larger than in the predictions which keep
expenditure profiles constant’’[4] p 582.
From the quote above, steepening may be seen as a
contradiction to the more optimistic future scenarios
described in the red herring debate [2], which claim that
future health care expenditures will be lower than previ-
ously expected, due to an increased length of life. How-
ever, as we will return to in the end of this section, both
hypotheses may in fact hold at the same time. Before the
link between the terms is explained in more detail, we will
summarize the literature on the steepening and briefly
mention the red herring literature.
Steepening
In 2006, a new term regarding health care expenditures and
older people was introduced by Buchner and Wasem [4]
that suggested per capita health care expenditures would
grow faster for the elderly than for younger people, i.e., a
situation characterized by steepening. Steepening was
defined as the increase in the ratio of per capita expendi-
tures for older people (65?) divided by the younger (below
65), over time:
Ya2½65;106;t=Ya2½0;64;t [ Ya2½65;106;t1=Ya2½0;64;t1 ð1Þ
where Ya2½65;106;t is the per capita expenditures for the
elderly (aged above 65?) in year t.
Note that in their regression analysis they defined the
young to be between 30 and 64, while the old were
between 65 and 79 [4]. To make the age limits more
comparable with the other definition (2) of steepening
presented in this paper, we will use the age limits as pre-
sented in definition (1) throughout this paper. Also note
that Buchner and Wasem [4] include other definitions of
steepening that we will return to in the ‘‘Methods’’ section.
Based on the same definition, but without using the term
steepening, health data from OECD between 1984 and
1998 indicates steepening in several countries, among them
the United States (US), Finland and Japan. However, this
pattern is not found in the UK [7], where a decline in the
expenditures for the elderly compared to the rest of the
population is observed. There are also other studies that
suggest health care expenditures grow faster for the elderly
than the rest of the population [8–11]. There are, however,
methodological issues connected to the simple method
(definition) used in these papers, which we will discuss in
more detail later. Some of the methodological issues are
solved by Felder and Werblow [5], who defined steepening
as a positive cross derivative of per capita health care




Note that Felder and Werblow [5] included mortality rates
in the function of per capita expenditures, in contradiction
with the definition by Bucher and Wasem [4], as they
defined steepening in three dimensions (age, per capita
expenditures and time). Therefore, in the rest of this section
we will ignore the impact of mortalities.
Definition (2) forms the basis of this paper, but results
based on both definitions (1) and (2) will be presented later.
The reason for focusing on the latter definition is that the
definition is more flexible with respect to model specifi-
cation, and in our view it captures the concept as it was
originally formulated by Bucher and Wasem [4]. A wider
discussion on the different definitions of steepening will be
presented in the methods section.
Felder and Werblow [5] mention several factors that
may lead to steepening or reduce the effect of steepening.
We will give a short summary in the following section.
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They suggest that steepening may arise due to increased
‘‘maintenance’’ costs as length of life increases, or simply
as a bias in the technological frontier (more innovations in
medical treatments for older people). They also mentioned
that, to the contrary, per capita mortality-related expendi-
tures for hospitals are decreasing with age; hence,
increased length of life might reduce mortality-related
expenditures. This is supported in several studies [12–14].
Felder and Werblow [5] also suggest that, due to com-
pression of morbidity, the period of illness will be com-
pressed over time, which will in turn reduce the per capita
health care expenditures related to older people [15].
Another paper discussing the reasons for growth in health
care expenditures for the elderly is written by Barer et al.
[11]. They discuss the implications of changes in morbidity
and mortality and how that might change utilization for
health care. Their study is formed around rectangularization
of survival curves over time, compression of mortality [16],
and compression of morbidity [15]. They argue that based on
the preferences of society to either accept ‘‘natural death’’ or
use all resources possible to reduce morbidity, the com-
pression of mortality and morbidity will influence health care
expenditures in different ways. If society accepted ‘‘natural
death’’, health care expenditures for the elderly will drop
over time, while if society minimizes morbidity it will
increase expenditures for elderly.
In summary, the literature on the causes of increased
expenditures for the elderly indicates that there might be a
technological bias and changes in biological factors (mor-
bidity). With regard to the first, the technological bias is
likely to be driven by some underlying mechanisms that are
poorly explained by Felder and Werblow [5]. One reason
might be biological changes over time, but there could also
be other mechanisms driving steepening.
Red herring
The red herring hypothesis was formulated by Zweifel
et al. [3], and states that health care expenditures are driven
by time to death and not age per se. A similar idea had
previously been presented by Fuchs [17]. Zweifel et al. [3]
formulated precisely as:





where a is age and k is quarters to death.





Several studies have tested the red herring hypothesis
(see, among others, [2, 18, 19]); i.e., the studies have tested
how time to death and age for a sample of the population
may explain the observed health care expenditures. Some
of the studies reject, while other support, the red herring
hypothesis.
In the red herring debate, several methodological
problems have been raised (see. among others. [20, 21]).
The debate is summarized in Ha¨kkinen et al. [22] by
pointing at two econometrical issues: first, multicollinearity
between the explanatory variables (age and time to death),
and second, endogeneity between health care expenditure
and time to death (mortalities). Both these issues will be
relevant in the ‘‘Methods’’ section in Eqs. 10, 11, 14 and
16. Gregersen and Godager [13] apply the same data set as
we do in this study, and discuss both these issues in detail.
In summary, first, the multicollinearity is of minor impor-
tance, as the data set is large; second, the assumption that
mortalities are exogenous is not rejected.
The link between steepening and red herring
By definition, steepening is defined in three dimensions
(age, time, and per capita health care expenditures) as is the
red herring (age, time to death and individual health care
expenditures). As the dimensions in the terms differ with
respect to time and time to death, the link between the
terms is not obvious, and both hypotheses may hold at
once. Furthermore, when comparing (2) (steepening) with
(3) and (4) (red herring), the definitions of the terms do not
contradict or support each other. In summary, we therefore
conclude that the terms are independent.
Data
For this study, we have repeated cross-sectional data
(pseudo-panel) for all hospital admissions in Norway from
1998 until 2009. The data comes from the Norwegian Patient
Registry (NPR). The data was merged with demographic
characteristics from Statistics Norway (SSB). The data from
NPR provides a complete registry of all hospital admissions
in Norway from January 1998 to December 2009. The
dataset contains data on somatic in patient care. Registration
in NPR is compulsory for all hospitals, and therefore there is
no self-selection in the dataset. Each admission to the hos-
pital (hospital stay) is registered as an observation, and it is
not possible to track individuals between admissions. The
dataset contains five variables; year of birth, gender, year of
hospital stay, DRG-points (diagnostic related group) and
place of residence of the patient (municipality). Data on the
number of inhabitants (N) are given by SSB (Table 1).
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In order to get per capita measures, we aggregated the
data by grouping the data so the smallest possible cell is
defined by a given age (ai), gender (qi), year (ti) and
municipality (mi). The 430 municipalities, 106 ages, 2
genders and years of observation (1998–2009) gave
1,093,920 unique cells that form the dataset our analysis is
based on. We index the cells with the index g (g = 1,
2…,1,093,920).













For the rest of this paper, the expenditure will be
measured in Norwegian kroner (NOK), inflation adjusted
to 2010 NOK {8 NOK = 1 € [Norwegian Bank (2010)]}.
In Fig. 1 we present per capita expenditures as a function
of age. To explore how expenditures have developed over
time for different age groups, we compared the per capita
expenditures for the first 6 years with the last 6 years in the
dataset. We aggregate the total health care expenditures for
each age (a) and divide by the number of inhabitants with
age (a), for each of the two time periods (1998–2003 and
2004–2009). If we denote the start of a period by t1 and the
end by t2 (for example t1 = 1998 and t2 = 2003) the health
care expenditures for age (a) in Fig. 1 is defined by:
Y




i2 a;t2 t1;t2½ f g
Yi: ð7Þ
The figure clearly shows that the per capita health care
expenditures for the older people and newborns (0 years
of age) have increased substantially over time during the
period of observation. Except for newborns, the expen-
ditures for older people increased more than for the rest
of the population. If newborns are excluded, the figure
shows that the expenditures for older people have grown
faster than for the rest of the population, consistent with
steepening.
One reason for the increase in expenditures for new-
borns may be increased expenditures for premature infants.
Both Bratlid and Nordermoen [23] and Nordermoen and
Bratlid [24] discusses the increases in treatment expendi-
tures for treatment of premature infants in Norway. In
summary, they highlight that more premature infants with
low birth weight are treated, and advances in technology
not only increase the cost of treatment, but also improve
the quality of the treatment.
Table 2 compares demographic characteristics for the
first 6 years (1998–2003) in the data set with the last
6 years (2004–2009). Comparing the two periods, the
average annual number of inhabitants has increased from
4.5 million in the first period to 4.7 million in the last
period. The total number of decedents does decline over
time, comparing the same two periods from 263,627 to
249,902. The mortality rate (number of decedents divided
by the total population) for most age groups is falling over
time, apart from the age groups containing the individuals
aged between 5 and 14.
Methods; identifying steeping
In Buchner and Wasem [4], three methods are presented
with which to identify steepening. The first is based on
definition (1); using this approach, they find clear evidence
of steepening. As they state, the clear advantage of this
simple method is that it is transparent and easy to replicate.
On the other hand it does not investigate changes within the
two age groups—the younger and older people. This is
closely related to:
Ya2½65;106;t=Ya2½0;64;t ¼ w0 þ w1  t: ð8Þ
Second, they suggest a slightly modified method, using a
benchmark age group, and compare the growth of the other
age groups relative to the benchmark age group:
Ya;t
Ybenchmark;t
¼ k0;a þ k1;a  t: ð9Þ
Finally, they suggested a model with health care
expenditures as an exponential function of age. Buchner
and Wasem [4] only had 20 age groups and two genders,
each year for 18 years (20 9 18 9 2 = 720 observations).
The data limitations put strong limitations on their
regression methods. The methods were later significantly
improved by Felder and Werblow [5]. They had more
variation in the data (a larger data set) with 26 regions, both
genders, 10 years and 20 age groups, i.e., 10,400
observations. This allowed for a more complex model.
They assumed that the health care expenditures are a
function of time (t) and demographics [age (a), gender (q)
and mortality rate ð/Þ]:
Per capita health care expenditure
¼ Constant þ b  gender þ c  age þ h  time
þ j  mortality rate þ l  age  time þ error term $
ð10Þ
Yg ¼ a þ b  q þ c  a þ h  t þ j  /g þ l  a  t þ eg:
ð11Þ
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In Eqs. 10 and 11,1 b indicates the marginal increase in
cost for females compared to males, and h captures yearly
growth in per capita expenditures, while l measures the
age specific growth rate as deviation from the yearly
growth rate (h), j is the increase in per capita hospital
expenditures due to mortality rate, and c is the impact of
age on per capita expenditures. Finally, e is the error term.
In this setting, steepening was defined by (2).
Note that Felder and Werblow [5] argue that hospital
expenditures grow exponentially over time. To test if an
exponential or linear model applies to our data set, we ran
two regressions: first, keeping the dependent variable as a
linear function of time, and second, keeping the dependent
variable as an exponential function of time:
Yg ¼ h0 þ h1  t ð12Þ
with R2 = 0.0095 and ln Yg ¼ h0 þ h1  t with
R2 = 0.0019.
From Eq. 12 we see that the R2 is low in both the
exponential and linear model, but slightly higher in the
linear model. Based on the result, the difference between
the two models is small and both models may apply.
However, we choose to apply a linear model due to the
slightly higher R2.
Felder and Werblow [5], argue that o
2Y
oaot is a function not
only of la, but also of the mortality rate /. They assume
that o
2/
oaot \0 due to increased length of life. Therefore, we
tested the magnitude of changes in mortality rate from
changes in age and time:
/g ¼ a0 þ a1  t  a þ a2  a þ a3  t þ eg: ð13Þ
In the rest of the methods section, we will ignore the
impact of changes in mortalities on steepening, but we will
come back to this issue in the results section.
Further, as stated earlier, Felder and Werblow [5] only
had 20 age groups (dz) in their data set, limiting their
analysis to 14. As we have more variation in the age var-
iable, we are not forced to keep the same grouping of the
regression parameter. However, per capita expenditure is
not a linear function of age (see Fig. 1); therefore, we also
treat age as a categorical variable, with 21 groups,
respectively. The reasons for keeping age to 21 groups only
are twofold. First, it will make the results easier to compare
to the methods presented by Felder and Werblow [5].
Second, if age is treated with one-year age-groups, the
number of observations in each group declines, and
therefore the precision of each estimate will drop. In
summary, as the estimate of interest here is the differences
in growth between the young and old, and not the specific
growth rate for each age per se, we therefore find the
grouping similar to the one found in Felder and Werblow
[5] to be sensible in this analysis:
Yg ¼ a þ b  q þ
X20
z¼0







lzdz  t þ eg ð14Þ
dz is a dummy for indicating age group (0, 1–4, 5–9,
…, 90?), em;a;t;q represents the error term, and lz
measures the deviation in growth rate for age group z
compared to the young [below 50 (z \ 11)]. As lz2f1;10g
is the benchmark age group, steepening is for age group
z as defined by:
lz  lz2f1;10g [ 0 for z [ 10, indicating that the growth
rate for the elderly is higher than for the young.
Steepening within the 50? age group is defined by
lzþ1  lz [ 0 for z [ 10.
The reasoning for choosing the specific functional
form to capture the mortality-related expenditures in
Table 1 Descriptive statistics: expenditures
Variable Number of observations Mean Std. dev. Min Max
Per capita expenditures by year: Yt ¼ 1Nt
P
i2t
Yi 12 7,340.71 947.5119 5,786.21 8,595.46
Per capita expenditures by group: Yg ¼ 1Ng
P
i2g





























Fig. 1 Hospital expenditures per capita measured in NOK over age
1 Note that g denotes a cell in the data set applied in this study,
characterized by age, gender, time and municipality.
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Eq. 14 is poorly described by Felder and Werblow [5].
From several papers [12–14], it is known that mortality-
related health care expenditures are a decreasing function
of age. We therefore include the interaction between age
and mortalities ðage  /Þ in our analysis. Furthermore,
we cannot find any studies supporting the inclusion of
mortalities to the power of two, three and four (x = 2, 3,
4). We therefore choose to only include mortality rate to
the power of one (x = 1). The number of mortalities,
due to compression of morbidity, increases for the
highest age groups (see Table 2). We would therefore
expect, as mortality related expenditures decrease with
age, to observe a reduction in the mortality related
expenditures over time. To capture the latter effect, we
include the interaction between mortalities and time,




Finally, we also include the yearly growth rate for all
age groups (lz, z = 0, 1, ..., 20), to identify differences
within the young. We are now left with the equation that
forms the basis of our analysis:
Yg ¼ a þ b  q þ
X20
z¼0




lz  dz  t þ k  /g  t þ eg ð16Þ
We note that the error terms in Eqs. 10–16 are
heteroscedastic, due to variation in the size of the cells,
Ng. We therefore weight the regressions by the number of
inhabitants in each cell.
Results
This section will present estimations based on the methods
presented in methods section. The share of the per capita
health care expenditures used by the elderly (65?) does not
increase over time (1998–2009) (Table 3). This holds even
though we exclude the newborns. On the contrary, the
share used by the younger group is highest in 1998. The
estimation based on Eq. 1, therefore, does not support
steepening. When running a regression on Table 3,
equivalent to (8), we find a negative and significant effect
Table 2 Descriptive statistics: demographic characteristics
Age 2004–2009 1998–2003 Mortality rate
1–mortality rate 2
#Decedents Inhabitants Mortality rate 1 #Decedents Inhabitants Mortality rate 2
0 943 351,791 0.002681 1,146 342,773 0.003343 -0.0007
1–4 359 1,390,934 0.000258 531 1,420,461 0.000374 -0.0001
5–9 192 1,795,174 0.000107 231 1,827,422 0.000126 0.0000
10–14 186 1,868,604 0.0001 222 1,752,313 0.000127 0.0000
15–19 607 1,834,645 0.000331 718 1,591,994 0.000451 -0.0001
20–24 995 1,681,558 0.000592 1,168 1,634,271 0.000715 -0.0001
25–29 1,173 1,728,377 0.000679 1,378 1,886,462 0.00073 -0.0001
30–34 1,252 1,932,635 0.000648 1,681 2,077,068 0.000809 -0.0002
35–39 1,791 2,130,113 0.000841 2,084 2,000,640 0.001042 -0.0002
40–44 2,416 2,066,621 0.001169 2773 1,903,477 0.001457 -0.0003
45–49 3,699 1,931,564 0.001915 4,049 1,835,113 0.002206 -0.0003
50–54 5,741 1,847,509 0.003107 6,505 1,807,816 0.003598 -0.0005
55–59 8,617 1,776,023 0.004852 8,690 1,550,439 0.005605 -0.0008
60–64 12,527 1,586,827 0.007894 10395 1,148,655 0.00905 -0.0012
65–69 14,342 1,137,507 0.012608 14,833 1,004,696 0.014764 -0.0022
70–74 18,734 925,269 0.020247 24,233 989,335 0.024494 -0.0042
75–79 29,838 848,292 0.035174 39,216 941232 0.041,665 -0.0065
80–84 45,382 725,662 0.062539 50,893 716,681 0.071012 -0.0085
85–89 51,417 475,017 0.10824 49,216 405,885 0.12126 -0.0130
90? 49,691 244,942 0.20287 43,665 200,843 0.21741 -0.0145
Sum 249,902 28,279,064 263,627 27,037,576 -0.053386
Average sum by
year (sum/6)
41,650 4,713,177 43,938 4,506,263
984 F. A. Gregersen
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when including all ages w1 ¼ 0:021. Furthermore, when
excluding individuals \1 year of age, we find a positive,
not significant effect w1 ¼ 0:003. Overall, the estimation
effect based on (1) and (8) rejects steepening.
To identify steepening in Eqs. 10, 11, 14 and 16, the
magnitude of the changes in mortality over time has to be
identified. As discussed in the methods section, mortality
rates are decreasing over time, i.e., there is a compression
of mortalities (see Table 2). From the regression on (13),
we find the effect to be small, significant, and negative
(a1 ¼ 0:0000085) (see Table 4). To also estimate the
effect of changes in mortality rates over time in (14), i.e.,
mortality rate to the power of 1, 2, 3 and 4, we also
included regressions with the mortalities to the power of 2,
3, and 4 as the dependent variable in Table 4.
Table 5 presents four regressions. The first is based on
Eq. 14 in the ‘‘Methods’’ section. As expected, the age
coefficient for the younger age group is low (below 25),
apart from the 0-year-olds. The age coefficient peaks for
the 70–75-year-olds. For the highest age groups, there is a
decline compared with the age group 70–75. We may not





x¼1 jx /ð Þx
oaot
¼ lz lz2 1;10f g
þo
2P4
x¼1 jx /ð Þx
oaot
¼ lz lz2 1;10f g þ131415:8





Within the group of older people (above 50), we find
steepening for all age groups ðlzþ1  lz [ 0Þ apart from
Table 3 The share of total health care expenditures spent on the
elderly compared to the rest of the population
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the highest age group, above 90 ðl20  l19\0Þ. Further-





females have higher expenditures than males on average.
Second, the regression output based on Eq. 16 excludes
mortalities. In this regression, the 0-year-olds have the
highest yearly growth, of 2,700 NOK l0 ¼ 2700:4ð Þ. The
second-highest yearly growth is found for the 80–85-year-
olds, with 939.4. In comparison, the 5–9-year-olds have a
yearly growth rate of 38.12. The annual growth for young
individuals (i.e., below age 50) is lower than for those
individuals age 50 or greater, that is, apart from the new-
borns. This does not reject steepening if newborns are
excluded.
Third, the regression output based on Eq. 16 is pre-
sented, but now including the effect of mortalities, while
excluding the interaction between time and mortalities. As
expected, the effect of mortalities is positive, and as
expected the mortality related cost is a decreasing function
of age. Also, the age effect is slightly reduced here for each
age group, implying that part of the expenditures for each
age group is generated by mortalities. Especially for the
highest age groups, there is a decline from a model
excluding mortalities. The yearly growth rate for the dif-
ferent age groups are similar to the previous (second)
results presented, and the same interpretation regarding
steepening applies.
Finally, the results from running a regression on Eq. 16
both including the effect of the interaction of mortalities
and time are presented. When the interaction of time and
mortalities are included, the yearly growth rate is declining
for all age groups, apart from the 1–4 group. The yearly
growth for the 90? was 976.4; after the inclusion of the
interaction term it became 548.5, implying that part of the
growth for the highest age groups is caused by increased
mortality related costs over time ðk ¼ 2045:9Þ.
To summarize the results in Table 5, the first regression
does not reject steepening (based on Eq. 14). In the fol-
lowing three regressions presented (based on Eq. 16), we
can also not reject steepening if excluding individuals
below age 1.
Conclusion and discussion
The first part of this paper clarified the connection between
steepening and the red herring hypothesis. We concluded
that the terms are independent. Furthermore, the data
applied in this study is insufficient to test the red herring
hypothesis. The reason for the data ‘‘insufficiency’’ is that
the data do not contain information on time-to-death at the
individual level. Therefore, the data may not reject the
hypothesis as formulated by Zweifel et al. [3], i.e. (3) and
(4).
The first part of this paper continued with summarizing
causes mentioned in the literature that may induce steep-
ening. In summary, the literature is limited and points at
biological and technological factors.
The second part of this paper was to test steepening.
Steepening was defined by Buchner and Wasem [4] in three
dimensions: time, age and per capita health care expendi-
tures. In these dimensions, the term states that health care
expenditures should grow faster for older people than the
rest of the population. In these dimensions, we find evi-
dence of steepening with the exception of the 0-year-olds,
i.e., Eq. 16, excluding mortalities. The method is similar to
the method found in Felder and Werblow [5]. When using
definitions (1) and (8), similar to the methods suggested by
Buchner and Wasem [4], we find no evidence of steepen-
ing, including all ages. However, when excluding the
individuals aged zero, we find a non-significant effect in (8)
in favour of steepening. Our results are not directly com-
parable to Buchner and Wasem [4], as they only included
individuals between 30 and 70 years of age in their study.
Regardless of the age limits used, the latter model has little
flexibility within the age groups (young and older), as there
is only one dummy for each group. From Fig. 1, it is clear
that per capita health care expenditures is not a linear
function of age, and a model allowing for more variation is
more appropriate. Overall, we therefore find the results
based on Eq. 16, excluding mortalities, to be more reliable.
The second step in our empirical estimations was then to
estimate what factors may drive the steepening effect.
From several studies, among them Zweifel et al. [3] and
Seshamani and Gray [25], mortalities are an important
driver of health care expenditures. We would therefore
expect the effect of steepening to be reduced in Eq. 16,
including mortalities. In Table 5, it is shown that such a
decrease does not occur. However, when including the
interaction between mortalities and time, the steepening
effect strongly declines, i.e., part of the steepening effect is
driven by increased mortality-related expenditures over
time.
Several implications follow from the results. First, as
shown in several other studies (see, among others, [12, 26])
both mortality and age contribute to health care expendi-
tures. Second, per capita health care expenditures are
biased towards older individuals over time. Per capita
health care expenditures for infants are increasing more
than for the rest of the younger population. Third, if the
observed trend continues, expenditures for older individu-
als are likely to increase substantially in the future (both
2 oYg
o/g
¼ j1 þ 2j2/g þ 3j3/2g þ 4j4/3g ¼ 131416  2  446127  /g
þ3  640520  /2g  4  310920  /3g [ 08/g:
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Table 5 Results from regression analysis based on Eqs. 14 and 16
Dependent variable per capita expenditures ðYgÞ
















Year (t) t = 0 if
year = 1998 t = 1 if
year = 1999 … t = 11 if
year = 2009 ðhÞ
142.1*** (2.024)
t 9 age ðlÞ
t 9 age 0 2,700.4*** (14.75) 2,731.0*** (14.39) 2,725.1*** (14.38)
t 9 age 1–4 76.86*** (7.365) 82.03*** (7.184) 81.43*** (7.181)
t 9 age 5–9 38.12*** (6.545) 38.74*** (6.384) 38.52*** (6.381)
t 9 age 10–14 44.18*** (6.598) 45.24*** (6.436) 45.02*** (6.433)
t 9 age 15–19 58.88*** (6.699) 62.99*** (6.534) 62.24*** (6.531)
t 9 age 20–24 53.80*** (6.751) 58.96*** (6.584) 57.71*** (6.581)
t 9 age 25–29 56.33*** (6.454) 58.06*** (6.295) 56.65*** (6.292)
t 9 age 30–34 97.25*** (6.250) 101.9*** (6.096) 100.4*** (6.093)
t 9 age 35–39 130.4*** (6.152) 136.8*** (6.001) 135.0*** (5.999)
t 9 age 40–44 147.7*** (6.202) 155.7*** (6.049) 153.1*** (6.047)
t 9 age 45–49 164.5*** (6.401) 173.0*** (6.243) 168.9*** (6.242)
t 9 age 50–54 51.53*** (6.710) 183.3*** (6.454) 195.5*** (6.295) 188.6*** (6.296)
t 9 age 55–59 115.2*** (7.236) 243.0*** (7.008) 259.7*** (6.836) 249.3*** (6.842)
t 9 age 60–64 247.9*** (7.741) 371.8*** (7.537) 393.0*** (7.352) 375.7*** (7.372)
t 9 age 65–69 368.6*** (8.509) 476.6*** (8.336) 509.2*** (8.132) 481.4*** (8.182)
t 9 age 70–74 552.0*** (9.058) 625.7*** (8.901) 682.4*** (8.685) 636.8*** (8.816)
t 9 age 75–79 741.8*** (9.417) 790.2*** (9.268) 862.5*** (9.045) 783.7*** (9.421)
t 9 age 80–84 819.3*** (10.61) 867.9*** (10.49) 948.9*** (10.24) 811.9*** (11.23)
t 9 age 85–89 866.5*** (13.28) 939.4*** (13.22) 1,021.8*** (12.90) 787.4*** (15.12)
t 9 age 90? 778.4*** (18.61) 913.5*** (18.64) 976.4*** (18.19) 548.5*** (23.19)
Gender ðqÞ 197.4*** (11.55) -92.59*** (11.58) 222.7*** (11.38) 222.7*** (11.37)
Age ðcÞ
0 23,927.5*** (57.03) 9,705.0*** (107.8) 8,761.0*** (105.3) 8,783.9*** (105.3)
1–4 Reference Reference Reference Reference
5–9 -1,554.6*** (33.81) -1,368.4*** (63.77) -1,283.1*** (62.20) -1,285.0*** (62.18)
10–14 -1,847.8*** (33.81) -1,678.6*** (64.59) -1,592.9*** (63.00) -1,594.7*** (62.97)
15–19 -1,093.4*** (34.23) -962.8*** (65.62) -960.5*** (64.00) -959.7*** (63.97)
20–24 -80.42* (34.49) 96.26 (65.16) 35.33 (63.55) 38.47 (63.52)
25–29 956.1*** (33.83) 1,108.1*** (63.06) 1,063.5*** (61.51) 1,067.2*** (61.48)
30–34 1,368.6*** (33.09) 1,306.3*** (62.16) 1,252.2*** (60.63) 1,256.5*** (60.61)
35–39 1,011.4*** (32.89) 799.1*** (62.62) 706.4*** (61.08) 713.0*** (61.05)
40–44 985.8*** (33.17) 722.4*** (63.06) 569.6*** (61.51) 580.1*** (61.48)
45–49 1,760.5*** (33.55) 1,496.4*** (63.69) 1,240.6*** (62.13) 1,258.7*** (62.10)
50–54 2,807.8*** (50.25) 2,885.2*** (63.74) 2,453.2*** (62.20) 2,486.0*** (62.19)
55–59 4,405.1*** (54.24) 4,731.7*** (66.91) 4,076.6*** (65.34) 4,127.6*** (65.33)
60–64 6,089.4*** (59.61) 6,813.5*** (71.24) 5,831.2*** (69.64) 5,919.5*** (69.68)
65–69 8,264.0*** (62.92) 9,649.5*** (73.68) 8,200.5*** (72.18) 8,347.5*** (72.31)
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due to increased expenditures towards elderly in general
and increased expenditures for decedents [based on
Table 5, last regression]). However, the implication of the
results with regard to predictions of future health care
expenditures should be interpreted with care until to the
mechanisms that drive steepening are detected.
The only health care service included in this study is
inpatient in somatic hospitals; this is a limitation to this
study. If there is a substitution effect between different
health care services, excluding other services could
potentially lead to biased results. It may be plausible that
steepening is observed for inpatients, but the opposite
effect is observed in other health care services. Additional
research should therefore take place in other parts of the
health care sector in order to confirm steepening outside
inpatient care.
The use of DRG-cost weights to measure expenditure
enables the study to investigate costs for different age and
gender groups over time. There are, however, some limi-
tations associated with using DRGs as a proxy for costs.
DRG-cost weights are the expected cost of a treatment for
the average patient and not the actual cost. As mentioned
by Melberg et al. [12], elderly individuals have poorer
health than the average patient, and the cost for this group
might therefore be underestimated. Conversely, for other
healthier groups, the use of DRG-weights may have over-
estimated actual costs.
In summary, our results clearly do not reject steepening in
per capita health care expenditures over time for the 50? age
group, with the exception of 0-year-olds. Mortality-related
expenditures also increase over time, and the effect of
steepening is reduced when this effect is taken into account.
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